THC Biomed Intl Ltd. (THCBF)

OTCMKTS · Delayed Price · Currency is USD

0.0010

0.00 (0.00%)

Mar 6, 2026, 4:00 PM EST

0.00% (1Y)

Market Cap	164.00
Revenue (ttm)	1.64M
Net Income (ttm)	-2.71M
Shares Out	163.94M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	394
Average Volume	8,271
Open	0.0245
Previous Close	0.0010
Day's Range	0.0010 - 0.0245
52-Week Range	0.0000 - 0.0245
Beta	-183.14
RSI	41.78
Earnings Date	Apr 2, 2026

About THC Biomed Intl

THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under the Always Hi brand name; and transport solution for young live plants under the Cloneshipper brand name. The company was founded in 2012 and is based i... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2012

Employees 35

Stock Exchange OTCMKTS

Ticker Symbol THCBF

Full Company Profile

Financial Performance

In fiscal year 2022, THC Biomed Intl's revenue was 2.45 million, a decrease of -6.80% compared to the previous year's 2.63 million. Losses were -3.07 million, -51.79% less than in 2021.

Financial numbers in CAD Financial Statements

News

There is no news available yet.